Actualité
RNA therapeutics and Neuroscience
- Recherche,
Date(s)
du 24 mai 2022 au 25 mai 2022
Lieu(x)
Virtual meeting: instructions to connect are communicated upon registration.
International Virtual Conference: RNA therapeutics and Neuroscience
The RNA & NEUROSCIENCE meeting aims to bring together graduate students, academic and industry scientists working in the fields of RNA and the Central Nervous System (CNS) to present their latest research results, ideas, developments, biological medical applications and discuss the current concepts and the challenges that we are facing for future research.
RNA therapeutics is a novel technology that provides a unique treatment for a variety of diseases. While it has been a success for the COVID19 pandemic, the RNA community still has the challenge on delivering some of these RNA molecules in other parts of the body (e.g. brain and cardiac tissue) and better specificity to have a full therapeutic effect. Therefore, this meeting will explore the novel RNA therapeutics that are been currently developing and their mechanisms to cure a variety of diseases.
Additionally, the complexity of the brain provides a unique challenge to find therapeutics to cure neurodevelopmental disorders and neurodegenerative diseases such as Alzheimer’s and ALS. These diseases are characterized by the lack of gene regulation causing protein imbalance at the synapses and therefore cell death. Thus, in this meeting we will also explore the mechanisms that cause these diseases and the novel therapeutics that are currently being developed for their cure.
This international conference is organised in the framework of the BIOPHARMACEUTICALS ARD CVL Programme.
CONVENORS
Dr Kathia Zaleta, LE STUDIUM / Marie Skłodowska-Curie Research Fellow
FROM: University of California San Diego (UCSD) - USA
IN RESIDENCE AT: Imaging and Brain Unit (iBrain), INSERM / University of Tours - FR
RNA therapeutics is a novel technology that provides a unique treatment for a variety of diseases. While it has been a success for the COVID19 pandemic, the RNA community still has the challenge on delivering some of these RNA molecules in other parts of the body (e.g. brain and cardiac tissue) and better specificity to have a full therapeutic effect. Therefore, this meeting will explore the novel RNA therapeutics that are been currently developing and their mechanisms to cure a variety of diseases.
Additionally, the complexity of the brain provides a unique challenge to find therapeutics to cure neurodevelopmental disorders and neurodegenerative diseases such as Alzheimer’s and ALS. These diseases are characterized by the lack of gene regulation causing protein imbalance at the synapses and therefore cell death. Thus, in this meeting we will also explore the mechanisms that cause these diseases and the novel therapeutics that are currently being developed for their cure.
This international conference is organised in the framework of the BIOPHARMACEUTICALS ARD CVL Programme.
CONVENORS
Dr Kathia Zaleta, LE STUDIUM / Marie Skłodowska-Curie Research Fellow
FROM: University of California San Diego (UCSD) - USA
IN RESIDENCE AT: Imaging and Brain Unit (iBrain), INSERM / University of Tours - FR
Prof. Patrick Vourc'h
Imaging and Brain laboratory Unit (iBrain), INSERM / University of Tours - FR
POSTERS
Abstracts for poster presentation should be submitted before Monday 25th April 2022.
Posters will be made available on the webpage of the conference as PDF files for the whole duration of the meeting. In addition, there will be a dedicated poster session each day. Poster presenters are asked to make a 3-minute / 1 slide of presentation during the session.
